Tradewind BioScience
Tradewind translates scientific insight into innovative ways of…
About
Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Founders (1)
Thaddeus Allen
Founder/CEO
Details
Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada, Remote, Partly Remote